Stelzer Laurie
- SEC CIK
- 0001644348
No open-market purchases or sales filed in the past year.
Current role at each company
- SION Sionna Therapeutics, Inc.Directoras of Jun 18, 2026
- PMVP PMV Pharmaceuticals, Inc.Directoras of Jun 5, 2026
- MBX MBX Biosciences, Inc.Directoras of Jun 5, 2026
- SYRE Spyre Therapeutics, Inc.Directoras of May 29, 2026
- MRTX Mirati Therapeutics, Inc.Chief Financial Officeras of Aug 10, 2023
Show 2 more companies
- SURF Surface Oncology, Inc.Directoras of Jun 10, 2022
- ARNA Arena Pharmaceuticals IncEVP & Chief Financial Officeras of Mar 11, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Stelzer Laurie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MRTX Mirati Therapeutics, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2023 (view filing) | Jun 2 | Same day | Stelzer LaurieChief Financial Officer | SSale | −4.65K | $37.06 | −$172.2K | −5.5%80.0K after |